Kazama Junichiro James
Division of Blood Purification Therapy, Niigata University Medical and Dental Hospital, Chuo-ku, Niigata, Japan.
Ther Apher Dial. 2011 Jun;15 Suppl 1:23-5. doi: 10.1111/j.1744-9987.2011.00923.x.
A quantitative histological analysis of biopsied bone samples is currently regarded as the gold standard for a diagnosing procedure for bone diseases associated with chronic kidney disease-related mineral and bone disorder. Conventionally, "bone cell activities" and "bone mineralization" are applied as two independent assessment axes, and the histology results are classified into five categories according to these axes. Recently, a new bone histology classification system called the Turnover-Mineralization-Volume system, which applied "cancellous bone volume" as another major assessing axis, was advocated; however, both classification systems have many unsolved problems. Clinicians must realize the limitations in evaluating bone metabolism by bone histology. We will need to establish a new classification method for renal bone diseases independent of histological findings.
对活检骨样本进行定量组织学分析目前被视为诊断与慢性肾脏病相关的矿物质和骨代谢异常相关骨疾病的金标准。传统上,“骨细胞活性”和“骨矿化”被用作两个独立的评估轴,并且根据这些轴将组织学结果分为五类。最近,一种名为“转换-矿化-体积”系统的新骨组织学分类系统被提出,该系统将“松质骨体积”作为另一个主要评估轴;然而,这两种分类系统都有许多未解决的问题。临床医生必须认识到通过骨组织学评估骨代谢的局限性。我们需要建立一种独立于组织学结果的肾性骨病新分类方法。